Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Director/PDMR Shareholding

6 May 2025 15:00

RNS Number : 5428H
Computacenter PLC
06 May 2025
 

 

 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

Computacenter plc

(the 'Company')

 

 

The following notification is made under article 19 of the Market Abuse Regulation ('MAR') relating to certain transactions in the shares of the Company by a Director and Person Discharging Managerial Responsibilities ('PDMR') of the Company.

 

The Company announces that its Chief Executive Officer, Mr Michael John Norris, sold 117,223 shares, on 1 May 2025. Following the sale Mr Norris retains 1,079,214 shares, including those held by a PCA.

 

The relevant FCA transaction notification can be found below.

 

PDMR/PCA FCA Transaction Notification

 

 

1.

 

 

Person Discharging Managerial Responsibilities

 

 

 

 

Name

 

Michael John Norris

 

2.

 

Reason for the notification

 

 

2(a)

 

 

Position/Status

 

Chief Executive Officer

 

2(b)

 

 

Initial Notification/

Amendment

 

 

Initial Notification

 

3.

 

 

Details of the issuer

 

 

3(a)

 

 

Name

 

Computacenter plc

 

3(b)

 

 

LEI

 

549300XSXUZ1I19DB105

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

 

Ordinary Shares acquired following exercise of a nil-cost option awarded under the Computacenter Performance Share Plan 2005 (the 'PSP Award'). There was no price payable on the grant or exercise of the PSP Award. Vesting of the PSP Award was subject to the achievement of a performance condition over a three-year period and released after a two-year holding period.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

Nil

 

110,977

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

Nil

 

 

 

110,977

 

4(e)

 

 

Date of the transaction

 

 

01-05-2025

 

 

4(f)

 

 

Place of the transaction

 

 

Outside of a trading venue. The Ordinary Shares for the above-mentioned exercise were satisfied out of those held by the 2011 Computacenter Employee Benefit Trust.

 

 

4.

 

Details of the transaction(s): Section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date and (iv) each place where transaction(s) have been conducted

 

 

4(a)

 

 

Description of the financial instrument

 

 

Ordinary shares of 7 5/9 pence in Computacenter plc ('Ordinary Shares')

 

ISIN: GB00BV9FP302

 

 

4(b)

 

 

Nature of Transaction

 

Sale of Ordinary Shares. Sold 110,977 shares acquired following the exercise of a nil-cost option vested and dividend equivalent 6,246 shares acquired under the Computacenter Performance Share Plan 2005.

 

 

4(c)

 

 

Price(s) and Volume(s)

 

 

Price(s) (in GBP)

 

 

Volume(s)

 

24.6839

 

117,223

 

4(d)

 

 

Aggregated Information

 

Aggregated Volume and Price

 

 

 

 

24.6839

 

 

 

117,223

 

4(e)

 

 

Date of the transaction

 

 

01-05-2025

 

 

4(f)

 

 

Place of the transaction

 

 

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADSKELASEFA
Date   Source Headline
19th Jan 20184:00 pmRNSDirectorate Change
14th Nov 20177:00 amRNSTrading Statement
27th Oct 20177:00 amRNSTrading Statement 3rd Quarter 2017
18th Oct 20173:46 pmRNSDirector/PDMR Shareholding
15th Sep 201711:30 amRNSDirector/PDMR Shareholding
7th Sep 20171:00 pmRNSHolding(s) in Company
25th Aug 20177:00 amRNSHalf-year Report
8th Aug 20172:30 pmRNSBlock listing Interim Review
5th Jul 201711:30 amRNSDirector/PDMR Shareholding
4th Jul 201711:30 amRNSDirector Declaration
21st Jun 20179:00 amRNSDirector Declaration
7th Jun 20171:30 pmRNSDirector/PDMR Shareholding
4th May 201710:00 amRNSResult of AGM
24th Apr 20177:00 amRNSTrading Statement 1st Quarter 2017
6th Apr 20171:30 pmRNSDirector/PDMR Shareholding
30th Mar 20172:45 pmRNSAnnual Report 2016 & Notice of AGM 2017
30th Mar 20177:00 amRNSDirector Declaration
29th Mar 20175:45 pmRNSDirector/PDMR Shareholding
29th Mar 201712:00 pmRNSDirector/PDMR Shareholding
27th Mar 20175:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20174:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20174:00 pmRNSDirector/PDMR Shareholding
13th Mar 20177:00 amRNSFinal Results 2016
8th Feb 201712:00 pmRNSBlock Listing Interim Review
23rd Jan 20177:00 amRNSPre-Close Trading Statement
10th Jan 20176:00 pmRNSDirector/PDMR Shareholding
14th Dec 20164:30 pmRNSDirector/PDMR Shareholding
1st Dec 20161:00 pmRNSDirector/PDMR Shareholding
28th Nov 20164:15 pmRNSDirector/PDMR Shareholding
28th Nov 20164:15 pmRNSDirector/PDMR Shareholding
17th Nov 201612:00 pmRNSDirector/PDMR Shareholding
15th Nov 201610:00 amRNSDirector/PDMR Shareholding
15th Nov 201610:00 amRNSDirector/PDMR Shareholding
11th Nov 20161:00 pmRNSDirector/PDMR Shareholding
11th Nov 20161:00 pmRNSDirector/PDMR Shareholding
11th Nov 20161:00 pmRNSDirector/PDMR Shareholding
11th Nov 201612:00 pmRNSDirectorate Change
10th Nov 201610:00 amRNSDirector/PDMR Shareholding
9th Nov 20166:00 pmRNSDirector/PDMR Shareholding
9th Nov 20166:00 pmRNSDirector/PDMR Shareholding
21st Oct 20167:00 amRNSQ3 2016 Trading Statement
20th Oct 201611:41 amRNSDirector/PDMR Shareholding
19th Oct 20164:30 pmRNSHolding(s) in Company
19th Oct 20164:30 pmRNSHolding(s) in Company
30th Sep 20165:23 pmRNSHolding(s) in Company
14th Sep 20165:59 pmRNSCompany Secretary Change
9th Sep 20163:00 pmRNSHolding(s) in Company
1st Sep 201610:30 amRNSDirector/PDMR Shareholding
26th Aug 20167:00 amRNSHalf-year Report
8th Aug 20162:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.